Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/2/2025

Drug Interactions Between Iguratimod and Duloxetine

Mechanism and Pharmacology

  • Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) metabolized primarily by CYP1A2 and CYP2D6 enzymes, used for depression, anxiety, neuropathic pain, fibromyalgia, and chronic musculoskeletal pain 1

Safety Monitoring Considerations

  • Common adverse effects of duloxetine include nausea, dry mouth, headache, constipation, and dizziness 1
  • Monitor for rare but serious effects including hepatic failure, severe skin reactions, and suicidal thinking 1
  • Check blood pressure periodically, as duloxetine can increase systolic and diastolic blood pressure 1

Clinical Application

  • Patients with rheumatoid arthritis requiring DMARD therapy who also have comorbid depression, anxiety, or chronic pain conditions may benefit from the combination of iguratimod and duloxetine 1
  • The combination is particularly useful when duloxetine addresses both mood symptoms and pain associated with inflammatory arthritis 1

Important Considerations

  • Do not confuse the lack of interaction between iguratimod and duloxetine with other drug combinations involving duloxetine that have significant interactions, such as duloxetine with MAO inhibitors, other serotonergic agents, or CYP1A2 inhibitors like ciprofloxacin 2, 3

REFERENCES

1

Duloxetine Scheduling and Clinical Applications [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Ciprofloxacin and Duloxetine Interaction [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025